Kintor Pharma prices IPO high to net $240m
Kintor Pharmaceutical has notched another success for the healthcare sector, raising HK$1.86bn ($240m) from its IPO after pricing the deal at the top of the marketed range.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: